These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16771788)

  • 1. Sublingual immunotherapy in children. Re: Marcucci et al.
    de Bot C; Moed H; van der Wouden JC
    Pediatr Allergy Immunol; 2006 Jun; 17(4):315; author reply 316-7. PubMed ID: 16771788
    [No Abstract]   [Full Text] [Related]  

  • 2. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
    Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
    Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of sublingual immunotherapy.
    Scadding G; Durham S
    J Asthma; 2009 May; 46(4):322-34. PubMed ID: 19484663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands.
    Marogna M; Massolo A; Colombo F; Isella P; Bruno M; Falagiani P
    Allergol Immunopathol (Madr); 2011; 39(2):60-7. PubMed ID: 21216083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year).
    Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G
    Pediatr Allergy Immunol; 2007 Feb; 18(1):58-62. PubMed ID: 17295800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma.
    Majak P; Rychlik B; Pułaski L; Błauz A; Agnieszka B; Bobrowska-Korzeniowska M; Kuna P; Stelmach I
    J Allergy Clin Immunol; 2010 Jun; 125(6):1220-7. PubMed ID: 20434204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to sublingual immunotherapy in preschool children.
    Pajno GB; Caminiti L; Crisafulli G; Barberi S; Landi M; Aversa T; Valenzise M; Passalacqua G
    Pediatr Allergy Immunol; 2012 Nov; 23(7):688-9. PubMed ID: 22985448
    [No Abstract]   [Full Text] [Related]  

  • 12. Sublingual immunotherapy.
    Esch RE
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):260-4. PubMed ID: 18475082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cluster immunotherapy in allergic rhinoconjunctivitis].
    Klimek L; Pfaar O
    MMW Fortschr Med; 2011 Feb; 153(7):34-6. PubMed ID: 21648138
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis and immunotherapy of mould allergy. With special reference to Cladosporium herbarum.
    Malling HJ
    Dan Med Bull; 1990 Feb; 37(1):12-22. PubMed ID: 2178885
    [No Abstract]   [Full Text] [Related]  

  • 15. [Are there specific treatments for allergic asthma?].
    Didier A; De Blay F; Tetu L; Dubus JC; Grimfeld A; Just J; Demoly P
    Rev Mal Respir; 2007 Oct; 24(8 Pt 3):7S41-51. PubMed ID: 18033202
    [No Abstract]   [Full Text] [Related]  

  • 16. [Allergen-specific immunotherapy in allergic rhinitis].
    Klimek L; Grevers G
    MMW Fortschr Med; 2008 Feb; 150(9):29-33; quiz 34. PubMed ID: 18402267
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study.
    Marogna M; Spadolini I; Massolo A; Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2010 Nov; 126(5):969-75. PubMed ID: 20934206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of sublingual immunotherapy.
    Passalacqua G
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():83-6. PubMed ID: 19221627
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy for Alternaria-induced allergic rhinitis: a randomized placebo-controlled trial.
    Cortellini G; Spadolini I; Patella V; Fabbri E; Santucci A; Severino M; Corvetta A; Canonica GW; Passalacqua G
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):382-6. PubMed ID: 21055665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.